- $41.42bn
- $45.61bn
- $2.86bn
- 87
- 22
- 73
- 63
Annual income statement for MSCI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,695 | 2,044 | 2,249 | 2,529 | 2,856 |
| Cost of Revenue | |||||
| Gross Profit | 1,404 | 1,685 | 1,844 | 2,082 | 2,342 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 856 | 1,008 | 1,041 | 1,144 | 1,328 |
| Operating Profit | 840 | 1,035 | 1,208 | 1,385 | 1,529 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 686 | 858 | 1,044 | 1,369 | 1,356 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 596 | 726 | 871 | 1,149 | 1,109 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 602 | 726 | 871 | 1,149 | 1,109 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 602 | 726 | 871 | 1,149 | 1,109 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.51 | 9.14 | 10.8 | 14.4 | 14.1 |
| Dividends per Share |